Wednesday, July 31, 2013

The Natural Power Of Homoepathy Drops

The Natural Power Of Homoepathy Drops
Homeopathic drops can be regarded as the ultimate answer to the demand for a natural, effective and fast acting weight loss solution. These Homeopathic drops really go to work on using up the fat stores ...

Can Fruit Make You Fat?

banana I heard a shocking conversation between two diners in a restaurant the other day. One lady was deciding whether or not she should have a green salad, fresh fruit or fries as a side dish with her meal. Her friend said, "don't get the fruit, it makes you fat." "Fruit makes you fat?" she asked. "It has tons of calories" replied the friend. The lady ordered fries with her meal.

...

Read Full Post

Source: weightloss.about.com

Summer Facials

Easy Summer Facials for Stressed Skin Summer heat can be exhausting, and long hot days can leave you feeling and looking tired and drained. Rejuvenate your skin with an invigorating summer facial and reveal a refreshed, smoother complexion. Tip from someone who knows how to treat hot, stressed skin. According to Jennifer Alvarez of Purely [...]

The post Summer Facials appeared first on Healthy Skin Solutions.

Easy Summer Facials for Stressed Skin

Summer heat can be exhausting, and long hot days can leave you feeling and looking tired and drained. Rejuvenate your skin with an invigorating summer facial and reveal a refreshed, smoother complexion.

Tip from someone who knows how to treat hot, stressed skin.
According to Jennifer Alvarez of Purely You Spa in Naples, Florida, switching between hot and cold treatments confuses the skin cells and makes them jumpstart the renewal process.

That’s good advice. Try it yourself with these easy recipes – a warming sugar scrub, followed by a cooling cucumber mask.

Spiced Sugar Scrub

This warming scrub removes dead skin cells and the spices will stimulate your skin by boosting circulation to give you a glowing complexion. You will need:

2 Tbs. Brown Sugar
1 Tbs. Honey
1 Tbs. Lime Juice
½ tsp. Cinnamon
½ tsp. Paprika

Combine the ingredients in a small bowl and stir until well mixed. Place the mixture in a microwave for about 10 seconds to warm it slightly.

Apply the scrub to your skin (avoiding the eye area) and gently massage in a circular motion for about 1 minute with your fingertips. Rinse with warm water and pat dry. Follow with this cooling and soothing mask.

Cooling Cucumber Mask

This chilled mask is the second step in your stimulating summer treatment. The temperature change immediately stimulates the skin and encourages cellular repair. The cucumber also has a calming effect on stressed skin. After your treatment you will notice brighter, smoother skin that will look and feel rejuvenated. You will need:

½ Cup Chopped Cucumber
¼ Cup Plain Yoghurt
1 tsp. Powdered Milk
2 tsp. Aloe Vera Gel

Combine all the ingredients in a blender and mix until smooth. Place the mixture in the refrigerator for 15 minutes to chill. Use your fingertips to apply the mask to your face and neck (avoid eye area) and leave it on for 20 minutes. Rinse with cool water and pat skin dry.

Make the Most of Your Facial Treatment

There are things you can do during and after your facial that will increase the benefits of the treatment.

During and after your facial and relaxing mask, sip water. Try adding a little antioxidant rich fruit like watermelon or simply add fresh lemon juice for a refreshing drink. Sipping water boosts the circulation and replaces fluids for additional hydrating effects.

During your relaxing mask, take a relaxing bath infused with dead sea salt or a nourishing milk bath. Or simply place a warm towel behind your neck and around your shoulders to relax tensed muscles.

After your mask, finish the treatment with a Vitamin C serum. Serums penetrate the skin more than creams and lotions, delivering more of the beneficial properties into the skin.

Want more summer skincare tips? We have loads of DIY recipes and remedies in our segments on Healthy Skin on a Budget and Home Remedies. Let us know what DIY skincare tips work for your heat stressed skin.

�

Why Are Antioxidant-Rich Face Masks So Important?

The post Summer Facials appeared first on Healthy Skin Solutions.

Get the whole story here.

Related Contents
http://dedomoge.ucoz.com/news/the_connection_between_sleep_deprivation_and_skin_damage/2013-07-23-1
http://lipenehe.livejournal.com/730.html
http://www.zimbio.com/Skin+Care/articles/l-PwOVhnoOG/Association+Between+Sleep+Deprivation+Skin

VIDEO: The fight for the right to die

Josh Cook, 22, talks about living with Huntington's disease and why he thinks he should be able to decide when to end his life. For complete story, click here.

Chanel’s Summer Collection: L’Été Papillon.

I’ve had a chance to take a good look at Chanel’s summer makeup collection, l’Été Papillon, and it’s really beautiful. In all honesty, as quite a “nude” makeup wearer, the bright butterfly colours didn’t instantly appeal to me but the campaign images were so gorgeous that I was prompted to [...]

makeup review

For me, the standout products are the amazing coloured mascaras – yellow, pale, limey green and a shocking blue. It’s quite a feat that Chanel have managed to create such pale shades yet formulate the mascaras in a way that the lashes still really stand out. I’ve tried a few shockingly bad coloured mascaras but Chanel’s are quite thick and really very pigmented. Light colours are never going to help define the eyes or create dark drama, but they do add a hell of a lot of interest! My bravest attempt at wearing them so far has been to use the pale green shade (above, “Lime Light”) on the mid-lengths and tips of my lashes, keeping the roots black for depth and definition.

face makeup review

I’m guessing that the most popular items in the collection will be the polishes – striking, bold colours that perfectly complement the face makeup range. Lilis is my favourite (I’m so predictable!) but the most show-stopping colour is the metallic blue, Bel-Argus. There’s also a whole selection of cooling shadow sticks (they really do cool the lids!) and glosses.

What do you think? Would you wear bright mascara? As you well know, I’m quite partial to a bit of bright blue (have it on right this minute, actually) but yellow? Pale green? I’m not sure I’m that avant garde with my makeup!

All of the l’Été Papillon collection can be found at counters nationwide and at Selfridges.com

Read the full article.

More To Explore
http://zemaxilu.newsvine.com/_news/2013/07/22/19624199-the-value-of-having-enough-sleep-for-youthful-skin
http://soyaroxo.bravejournal.com/entry/137557/
http://napumiha.skyrock.com/3175744527-Skin-Care-Techniques-Are-You-Getting-Adequate-Sleep.html

Tuesday, July 30, 2013

We're Slackin' On The Exercise

For full post, click here.

Abnormal blood sugar doesn't cause Alzheimer's

Abnormal blood sugar doesn't cause Alzheimer's
Conditions that cause problems maintaining normal blood sugar levels don't appear to be linked to specific signs of Alzheimer's disease, new research indicates.

Fit and Happy for Life (NO GUILT NEEDED!)

I love summer time! It's a cherished time for family BBQ's and much needed vacations. It can also be the time we are more conscious of our bodies and what we are putting in them. Before we know it, we are finding those smores we had around the campfire are adding to our "bottom" line. We throw in the sweat towel and munch our insecurities away. But wait! It doesn't have to be that extreme, what if you could have your smore and be fit too? This article will share with you how to be "Fit and Happy for Life" without the guilt or number crunching. It is time to love the skin we are in! Here is the full post.

Monday, July 29, 2013

Jay D. Miller Appointed Chief Executive Officer

WINNIPEG and MINNEAPOLIS, July 29, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that Jay D. Miller, the company's current President and COO, will also become the CEO of IMRIS Inc., effective August 1, 2013. Chairman and CEO David Graves will continue as the Chair of the Board of Directors of the Corporation.

"IMRIS has grown from a single idea into a business that impacts the lives of patients every day," said David Graves. "Our company has sold systems all over the world and is well positioned to enter into this next stage of growth under Jay's leadership. Since our inception we have successfully commercialized intraoperative surgery systems based on MR and now we have completed the intraoperative CT, which has the ability to put another strong revenue stream into the company. We have built a global sales capacity and customer base and have navigated some of the most challenging economic conditions in recent times. We are on track for the completion of the Symbis^® Surgical System, our MR-compatible Surgical Robot, and our MR-guided Radiation Therapy platform. We have a compelling line up of in-the-market and development stage products that will provide a strong foundation for the company as it goes forward. The goal of all IMRIS products is to improve patient outcomes and reduce the cost of care in the treatment of disease."

"The innovation and technology foundation at IMRIS was instrumental in my decision to join the company," said Jay Miller. "IMRIS is infused with a culture of excellence and a proven ability to commercialize technology. It is my goal to drive the adoption of products and services by customers and to provide great returns for investors. This is an exciting opportunity to lead the next phase in the growth of a world class medical device company."

Miller joined IMRIS in September 2012 as President and COO. Miller previously was the CEO of Zonare Inc., and CEO of Vital Images. Prior to that he held senior positions with GE Healthcare after starting his career with Siemens Medical Systems. He has a BA from Dartmouth, an MSc in Biomedical Engineering from University of Virginia and an MBA from Kellogg.

About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS^® Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS^® Surgical Theatres serve the neurosurgical, spine, cardiovascular and cerebrovascular markets.

SOURCE IMRIS Inc.

Source: www.prnewswire.com

Dispelling Common Myths About Miami Hypnosis

Many people refuse to even try hypnotherapy because they believe hypnosis is the same as they see in the movies or in a stage show; some type of act where the hypnotist gains control of people, who are then forced to embarrass themselves or reveal their deepest secrets.

Mini bottles, major colour—these neon nail polishes scream summer!

The post Mini bottles, major colour—these neon nail polishes scream summer! appeared first on beautyeditor.

Neons have seriously been everywhere this summer, from clothing and accessories to my most preferred form, nail polish. I’ll eventually tire of neon-everything, but I think a good neon nail will always work, especially in the heat of summer. OPI’s mini set of four colours, entitled Neon Revolution, hits the nail right on the head with this summer’s super-bright trend.

At first glance, the colours don’t look that bright all bottled up. I kinda felt like, okay, this is so not neon. What the F. But as I’ve mentioned before, OPI has a magical way of turning boring-in-the-bottle polishes to OMG GORGEOUS on the nail, just like that. I tell ya, I don’t know how they do it. So let’s get to it.

The set comes with a white base and a topcoat, so you literally have everything you need besides a base coat. The idea is to start with the white base, which makes the neon colour pop even more. I loathe white polish in general because I have yet to come across one that isn’t a terror to apply. They’re always insanely streaky and make me want to rip my hair out (I can get dramatic when it comes to polish). This white, however, wasn’t so bad. Still streaky, but I got away with one carefully applied coat. You’ll want to make sure that your white isn’t too streaky because the neons have a jelly consistency, meaning they’re a little see-through and slightly clear. A bad base will mean that you can see the streaky white underneath.

Blue It Out Of Proportion

Blue it Out of Proportion looks drab in the bottle but gets really neon-y really quick on the nail. Like, the colour was just waiting to escape, or something. It’s really bright and definitely stands out on your hand. Really easy to apply and looked great in two coats of colour.

Don’t Say It — Yellow it!

Don’t Say It — Yellow It! is a yellow highlighter. Literally. It’s so, so bright! My camera couldn’t even pick up how neon it was—the photos come off as more of a sunshine yellow when in real life it’s a true neon yellow. The only downside is that it was a bit harder to apply than the rest. After a white base + two coats, you could see a little streakiness, so three coats would be ideal for this one.

Pink Outside the Box

My favourite of the set, Pink Outside the Box, is a punchy pink. Barbie would totally make this her polish of choice and so would I. I didn’t want to take it off! So, so pretty and easy to apply.

The Time is Pow

The Time Is Pow is an orange traffic cone colour, which is ridiculously bright. Like, so bright! Just look at the photo, it’s practically glowing. I’m crazy for this shade in summer. Just imagine it on toes… swoon!

I think the collection is pretty spot-on considering everyone everywhere is neon-happy at the moment. Plus, you can’t help but cheer up a little with something this bright on your body, am I right?

So tell me:

Are you into the neon trend?
How do you feel about wearing it on your nails?
What’s your favourite neon polish?

The post Mini bottles, major colour—these neon nail polishes scream summer! appeared first on beautyeditor.

Synta Pharma shares soar after co says to expand breast cancer study

Synta Pharma shares soar after co says to expand breast cancer study
(Reuters) - Synta Pharmaceuticals Corp shares soared as much as 47 percent in heavy trading after the company said preliminary results from a mid-stage study of its drug ganetespib in breast cancer patients supported an expansion of the study. According to the design of the trial, it would advance to the second stage of enrollment if at least one patient achieved objective tumor response, a measure of reduction in tumor size. The study, codenamed ENCHANT-1, showed that four patients achieved an objective tumor response. ...

Herbal supplements could compromise surgery

Taking herbal supplements before cosmetic surgery could put patients at risk during their procedure, according to a study. Read more...

Sunday, July 28, 2013

Choking on food common among U.S. kids: study

Choking on food common among U.S. kids: study
By Genevra Pittman NEW YORK (Reuters Health) - Each day over the past decade, about 34 U.S. children went to the emergency room after choking on food, according to a new study of a group of nationally-representative hospitals. Researchers found that candy was the most common culprit - although choking on hot dogs, nuts and seeds most often required kids to be hospitalized. "These numbers are high," said Dr. Gary Smith, who worked on the study at Nationwide Children's Hospital in Columbus, Ohio. What's more, he added, "This is an underestimate. ...

Theresa May diagnosed with diabetes

Home Secretary Theresa May reveals she has been diagnosed with Type 1 diabetes, but insists it will not affect her political career. Continue reading...

This is My #1 Travel Body Creme!

PRODUCT REVIEW | BODY By Huda Heidi Kattan If you’ve tried Kiehl’s Creme De Corps than you know it is AhhhhhhhMAZING! I picked it up while I was in the airport recently and it’s got to be one of theقراءة المزيد Here is the full post.

See Also
http://miyuroki.jigsy.com/entries/general/opinions-regarding-organic-skin-care
http://putosoki.over-blog.com/everything-you-should-be-aware-about-organic-skin-care-products
http://guyascaend.blog.com/2013/07/23/organic-skin-care-products/

UK Woman Has Maggots Removed After They Burrowed Into Her Skin

Saturday, July 27, 2013

Pesquisa divulgada durante o Dia Mundial Contra a Hepatite mostra que os países estão mal equipados para lidarem com uma epidemia silenciosa

World Hepatitis Day Globe

LONDRES, 27 de julho de 2013 /PRNewswire/ -- No Dia Mundial Contra a Hepatite (World Hepatitis Day), a Aliança Mundial Contra a Hepatite (World Hepatitis Alliance) pediu que atenção urgente seja dada aos números recentes que mostram que apesar de a hepatite viral matar tantas pessoas quanto o HIV/AIDS, a grande maioria dos países não possui nenhum programa implementado para tratar da doença.

(Logo: http://photos.prnewswire.com/prnh/20130728/630031-a )
(Logo: http://photos.prnewswire.com/prnh/20130728/630031-b )
(Foto: http://photos.prnewswire.com/prnh/20130728/630031-c )
(Foto: http://photos.prnewswire.com/prnh/20130728/630031-d )

O estudo Carga Global da Doença, publicado no ano passado na revista Lancet, mostra que a hepatite viral foi responsável por quase 1.45 milhão de mortes em 2010, o mesmo que o HIV/AIDS e significativamente mais do que a tuberculose ou a malária. Apesar desta enorme mortalidade anual, os líderes da saúde global regularmente deixam a doença fora de suas agendas.

'A hepatite viral é a oitava principal causa de morte em todo o mundo, matando tantas pessoas quanto o HIV/AIDS todos os anos', disse Charles Gore, Presidente da Aliança Mundial Contra a Hepatite. '500 milhões de pessoas estão cronicamente infectadas. Perante estes números, como é possível que a hepatite viral receba tão pouca prioridade em todo o mundo?'

Atualmente, as doenças recebem atenção e recursos, dependendo de suas prioridades globais. Entretanto, a lista global de prioridades não reflete necessariamente a carga real da doença. Isto levou a respostas que são desproporcionais ao impacto das doenças e deixou algumas doenças tragicamente desprovidas de recursos. A hepatite viral é um exemplo claro; apesar de sua enorme carga, há pouca pressão global para cuidar desta doença. Consequentemente, a maioria dos governos deixou de dedicar recursos para a hepatite viral, mesmo em países onde a prevalência chega a 20%.

O Relatório Global lançado pela Organização Mundial de Saúde (WHO – World Health Organization) na semana passada, mostrou o quanto a hepatite viral é ignorada. Somente 37% dos países possuem uma estratégia ou plano nacional para a hepatite viral e menos de 30% reportaram ter um departamento responsável unicamente por atividades relacionadas com a hepatite viral. A falta de resposta para a oitava maior doença assassina do mundo é verdadeiramente incompreensível. Isso não somente põe em risco a vida de milhões de pessoas permitindo que esta epidemia silenciosa cresça, como também deixa abandonados, sem apoio ou reconhecimento, os 500 milhões de pessoas que estão cronicamente infectadas.

Em 2010 a Organização Mundial de Saúde reconheceu abertamente que a hepatite viral é um grande motivo de preocupação, tornando o Dia Mundial Contra a Hepatite um dos sete únicos dias mundiais de saúde oficialmente reconhecidos pela OMS e todos os Estados Membros. Entretanto, grandes mudanças no cenário da saúde global ainda deverão acontecer. Neste Dia Mundial Contra a Hepatite, a Aliança Mundial Contra a Hepatite lançou então uma campanha de conscientização em massa, sob o tema 'Isto é hepatite. Conheça. Confronte', para encorajar as pessoas a saberem mais e confrontarem o silêncio em torno da doença.

A Aliança também está coordenando uma tentativa global para entrar para o Livro Guinness de Recordes (Guinness World Record) pelo maior número de pessoas realizando as ações de 'não vejo, não ouço, não falo' ao mesmo tempo, as ações foram escolhidas porque da mesma forma que os Três Macacos Sábios ignoram o mundo ao seu redor, o mundo tem ignorado a hepatite viral. Com participação de 58 equipes de 25 países em todo o mundo, este é um desafio considerável, porém com uma mensagem bem clara: a hepatite viral é uma epidemia silenciosa. Conheça. Confronte.

Notas para o Editor

Aliança Mundial Contra a Hepatite

A Aliança Mundial contra a Hepatite é uma Organização Não Governamental abrangente com 165 grupos de pacientes membros em 66 países. Representando 500 milhões de pessoas que convivem com a hepatite viral em todo o mundo, a Aliança luta para apoiar e promover o apelo dos pacientes, para destacar o perfil da hepatite viral e estabelecer estratégias abrangentes contra a hepatite em todos os países. A Aliança Contra a Hepatite tem sido uma voz dominante na obtenção de vários sucessos para as pessoas que convivem com a hepatite, incluindo liderar a comunidade de pacientes na solicitação de uma resolução da OMS sobre a hepatite. Através de uma melhor conscientização, prevenção, cuidados, apoio e acesso ao tratamento, seu objetivo final é trabalhar junto aos governos para erradicar estas doenças.

Para mais informações, visite o endereço: http://www.worldhepatitisalliance.org

Dia Mundial Contra a Hepatite

No dia 28 de julho de 2013, a Aliança Mundial Contra a Hepatite coordenará o sexto Dia Mundial Contra a Hepatite que é um dos únicos quatro dias oficiais de conscientização sobre doenças específicas reconhecidos pela Organização Mundial da Saúde (WHO – World Health Organization) e endossados por seus 194 estados membros. O objetivo para 2013 é aumentar a conscientização sobre as hepatites crônicas B e C em todo o mundo e impulsionar a mudança das políticas para melhorias nos resultados da saúde para os pacientes.

Hepatites B e C

500 milhões de pessoas convivem com a hepatite viral crônica. Hepatites B e C são vírus 'silenciosos', porque as pessoas podem não apresentar nenhum sintoma. Se deixada sem tratamento e sem controle, a hepatite B ou C pode causar cicatrização avançada do fígado (cirrose), câncer hepático ou insuficiência hepática.

Contatos

Para mais informações, citações adicionais do porta-voz ou solicitações de fotos, por favor entre em contato com:

Hilary Campbell: Hilary.campbell@worldhepatitisalliance.org, +44(0)20-7378-0159

FONTE World Hepatitis Alliance

SOURCE World Hepatitis Alliance

Source: www.prnewswire.com

Arthur Murray Sends Six Students to Monte Carlo Dance Competition

Students of Arthur Murray Dance Studios are flying to Monaco to participate in the the Arthur Murray Monte Carlo Dance-O-Rama. The competition, which takes place over a five day period, begins on July...

(PRWeb July 27, 2013)

Read the full story at http://www.prweb.com/releases/2013/7/prweb10967162.htm

You Might Like
http://wallinside.com/post.php?id=4851723
http://konuxuri.sosblogs.com/The-first-blog-b1/Facts-And-Info-Concerning-Organic-Skin-Care-b1-p1.htm

Best Slim Herble Products Which Is Best in The Markert at SlimHerbal123

Best Slim Herble Products Which Is Best in The Markert at SlimHerbal123
Losing weight has enormous benefits for our lives. Not only are there physical and physiological benefits there are also the emotional benefits, which make us feel good about ourselves. Losing weight can also be hard ...

Friday, July 26, 2013

7 Weight Loss Foods

7 Weight Loss Foods
The food that we eat defines our lifestyle and defines how healthy we want to be and we can be. As we know, we should avoid fatty, sugary foods. But in times like these, where sweets are a commonality, it can be very hard to do. But there still are foods that can help bust those pounds. Here are some fat-busting, carb-less, nutritious food that can help contribute greatly to the body you'd want to have.

Music eases kids' pain during medical procedures

Music eases kids' pain during medical procedures
Music decreases children's pain when they're undergoing an uncomfortable medical procedure, according to a new study.

Facts About Garcinia Cambogia

Garcinia Cambogia is a plant native to Asia, Australia, Africa, and Polynesia. It grows as a beautiful evergreen tree. Recently, researchers have found that an extract of the fruit contains compounds which act as appetite suppressants and are useful for losing weight. More and more people each day are finding out how this wonderful plant can help them resist their cravings for food and slim down. As it is all natural it is a great option for those who do not want to ingest man-made compounds which are often found in other weight loss products. Source

Thursday, July 25, 2013

Nurses struck off over waiting times

Nurses struck off over waiting times
Two Stafford Hospital nurses who falsified A&E discharge times are struck off the nursing register.

Roche tops forecast as new cancer drugs gain momentum

By Caroline Copley BASEL, Switzerland (Reuters) - Swiss pharmaceuticals firm Roche beat first-half profit forecasts as strong sales of its mainstay cancer drugs and some new treatments supported its view that it can withstand competition from cheap, copycat drugmakers. The results also stoked speculation the group might hike its dividend, buy back shares and make more acquisitions as it looks to diversify from its core expertise in cancer. ...

Leslie Spry, M.D., FACP: Off the Cuff -- Which Alternative Blood Pressure Treatments Really Work?

Leslie Spry, M.D., FACP: Off the Cuff -- Which Alternative Blood Pressure Treatments Really Work?

You Might Be Interested In
http://www.quora.com/Krystal-Shortland/Posts/Basic-Things-To-Know-Regarding-Organic-Skin-Care-Products
http://www.dailystrength.org/people/3097690/journal/6692752

Children who can't stop eating

The children who just can't stop eating For complete story, click here.

Wednesday, July 24, 2013

Gesundheitsminister versprechen auf Internationalem Lepra-Gipfeltreffen Welt ohne Lepra; Nippon Foundation trägt 20 Millionen $ zum Kampf bei

TOKIO, 24. Juli 2013 /PRNewswire/ -- Das Internationale Lepra-Gipfeltreffen, organisiert von der Weltgesundheitsorganisation (WHO) und der Nippon Foundation aus Tokio, öffnete am 24. Juli in Bangkok, Thailand unter Teilnahme von Gesundheitsministern und anderen Vertretern aus 17 Ländern, in denen jährlich über 1.000 neue Leprafälle auftreten. Besorgt über dieses fortgesetzte Auftreten neuer Fälle veröffentlichten die Teilnehmer am 24. Juli eine Erklärung von Bangkok, in der weitere Anstrengungen zur Überwindung der verbleibenden Herausforderungen gefordert werden. Die Erklärung enthält das ambitionierte Ziel, das Auftreten von neuen Fällen mit sichtbarer Behinderung bis 2020 auf unter einen Fall pro eine Million Menschen zu reduzieren.

Yohei Sasakawa, Vorsitzender der Nippon Foundation, der sich seit über 40 Jahren für die Eliminierung der Lepra einsetzt, gab in der Vollversammlung anlässlich der Eröffnung bekannt, dass seine Stiftung über die kommenden fünf Jahre 20 Millionen US-$ für den Kampf gegen die Krankheit bereitstellen wird, und forderte die betroffenen Regierungen auf, ihre „Entschlossenheit zum Erreichen einer Welt ohne Lepra erneut zu bekräftigen."

Der Kampf gegen Lepra, eine der größten Herausforderungen in der Geschichte der öffentlichen Gesundheitsvorsorge, hat seit der Einführung der Kombinationstherapie in den 1980er Jahren große Fortschritte gemacht. In den vergangenen zwei Jahrzehnten konnten rund 16 Millionen Patienten geheilt werden. Aktuell ist Brasilien das einzige Land, das den von der WHO 1991 gesetzten Meilenstein der Eliminierung der Lepra als Problem der öffentlichen Gesundheitsvorsorge bzw. Reduzierung der Prävalenzrate auf unter einen Fall pro 10.000 Menschen auf dem nationalen Niveau noch nicht erreicht hat.

Trotz eindrucksvoller Fortschritte gibt Lepra immer noch Anlass zur Sorge in einigen Ländern, wo die Krankheit gebietsweise endemisch ist und das Auftreten neuer Fälle stabil ist oder gar einen Anstieg zeigt. Außerdem kommt es immer noch zu Diskriminierungen gegen an Lepra erkrankte Personen. Angesichts dieser Tatsachen zeigte Mr. Sasakawa, der auch WHO-Sonderbotschafter für die Eliminierung von Lepra ist, eine gewisse Beunruhigung und warnte vor Selbstgefälligkeit.

Das Gipfeltreffen findet an drei Tagen statt, an denen die Teilnehmer die aktuelle Lepra-Situation untersuchen, über Herausforderungen in den endemischen Ländern diskutieren und ihre Entschlossenheit ausdrücken, diese zu überwinden.

Kontakt:

Natsuko Tominaga
Public Relations Department
The Nippon Foundation
Tel: +81-3-6229-5131
E-Mail: pr@ps.nippon-foundation.or.jp

SOURCE The Nippon Foundation

Source: www.prnewswire.com

You Might Be Interested In
http://www.quora.com/Krystal-Shortland/Posts/Basic-Things-To-Know-Regarding-Organic-Skin-Care-Products
http://www.dailystrength.org/people/3097690/journal/6692752

Hill-Rom Reports Fiscal Third Quarter Adjusted Earnings Per Share In Line With Guidance; Provides Fourth Quarter And Updated Full-year Financial Outlook

-- Adjusted diluted earnings per share for the third quarter decreased 13 percent to $0.49 compared to $0.56 in the prior year

-- Reported diluted earnings per share for the third quarter increased 5 percent to $0.39 compared to $0.37 in the prior year

-- Year to date adjusted EBITDA of $223 million compares to $237 million in the prior year

-- Financial guidance: Full year reported revenue is now expected to increase approximately 5 percent with adjusted earnings per share to be $2.04 to $2.06; Full year adjusted EBITDA is now expected to be approximately $310 million

Hill-Rom Logo. (PRNewsFoto/Hill-Rom Holdings, Inc.)

BATESVILLE, Ind., July 24, 2013 /PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC) announced financial results for its fiscal third quarter ended June 30, 2013 and provided its fourth quarter and updated full year outlook. Adjusted earnings per diluted share of $0.49 were in line with the Company's guidance, but down 13 percent from $0.56 in the prior year. Reported earnings per diluted share increased to $0.39 from $0.37 in the prior year. Adjustments to reported earnings and EBITDA are detailed in the reconciliation schedules provided.

(Logo: http://photos.prnewswire.com/prnh/20130123/DE47178LOGO )

Hill-Rom's quarterly revenue was $424 million, a 4 percent increase compared to last year on both a reported and constant currency basis. Excluding the impact of Aspen, revenue declined approximately 3 percent. Domestic revenue was $281 million, up 9 percent, while revenue outside the United States decreased 3 percent to $143 million.

Management Comments

"Despite revenue slightly below our expectations, we are pleased to report adjusted earnings in line with our guidance and stable adjusted gross margin compared to the prior year," stated John Greisch, President and CEO. "The healthcare environment remains challenging and we will continue our focus on initiatives to improve margins and maintain our strong, consistent cash flow."

Financial and Operational Highlights

-- Third quarter revenue highlights include:

-- North America. North America revenue declined 1 percent to $239 million. Capital sales increased 2 percent with U.S. Patient Support Systems revenue flat versus the prior year and up 16 percent sequentially. Rental revenue declined 6 percent due partially to our exit from certain home care categories.

-- International. International segment revenue decreased 8 percent to $123 million (9 percent on a constant currency basis) due to declines in capital sales in Eastern Europe and the Middle East.

-- Surgical/Respiratory Care. Surgical/Respiratory Care revenue increased 95 percent to $62 million, due to the addition of the Aspen business. Excluding Aspen, segment revenue increased 2 percent on higher Allen Medical revenues.

-- Year to date operating cash flow was $168 million, compared to $187 million in the prior year.

-- Year to date adjusted EBITDA was $223 million, compared to $237 million in the prior year.

-- Share repurchases for nine months through June 30 amounted to approximately $70 million.

-- During the quarter, Hill-Rom announced a 10 percent increase of its quarterly dividend to $0.1375 per share, bringing the annual dividend rate per share to $0.55.

-- During the quarter, we launched the Allen Advance Table. This innovative product provides an advanced surgical platform for complex neurologic and spine procedures and provides enhanced surgical access regardless of patient position.

-- The Company also launched the Hill-Rom Hand Hygiene Compliance Solution to monitor proper hand-washing protocols to aid in the reduction of hospital associated infections. The new offering provides real-time monitoring, staff reminders, simplified reporting, and can use the same hardware as other Hill-Rom real-time locating solutions.

Please see the attached schedules for additional information, including condensed financial information, summary balance sheet, cash flow statement and reconciliations of GAAP to adjusted financial measures.

For a more complete review of Hill-Rom's results, please refer to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 to be filed later this week.

Financial Guidance Summary

For the fourth quarter of fiscal 2013, Hill-Rom expects reported revenue of $435 to $440 million. This reflects:

organic constant currency revenue essentially flat with the prior year;
no material currency impact at current rates; and
incremental revenue from Aspen of approximately $6 million.

Adjusted earnings per diluted share are expected to be $0.59 to $0.61 for the quarter.

Hill-Rom now expects full year reported revenue growth of approximately 5 percent compared to prior guidance of 5 to 6 percent. This reflects:

organic constant currency revenue decline of approximately 4 percent;
no material currency impact at current rates; and
incremental revenue from fiscal 2012 acquisitions of approximately $140 million.

For the full year, adjusted earnings per diluted share are now expected to be $2.04 to $2.06 compared to prior guidance of $2.03 to $2.09.

Cash flow from operations for the full year is expected to be $255 to $265 million compared to prior guidance of $270 to $280 million. Adjusted EBITDA is now expected to be approximately $310 million compared to prior guidance of $315 to $320 million.

Additional assumptions and discussion will be provided during the Company's conference call to be held tomorrow morning. Information to access the webcast is provided below.

Discussion of Adjusted Financial Measures

Hill-Rom Holdings, Inc. routinely provides earnings per share results and guidance on an adjusted basis because the Company's management believes that the presentation provides useful information to investors. In addition, we are providing adjusted earnings before interest, taxes, depreciation and amortization (adjusted EBITDA) for the same reason. These measures exclude strategic developments, special charges or other unusual events. Such items may be highly variable, difficult to predict and of a size that sometimes have substantial impact on the Company's reported operations for a period. Often, prospective quantification of such items is not feasible. Management uses these measures internally for planning, forecasting and evaluating the performance of the business. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

Reconciliations of GAAP measures to adjusted measures appear in the financial tables of this release.

Conference Call Webcast and Dial-in Information

As previously announced, the Company will host a conference call and webcast tomorrow morning on Thursday, July 25, 2013, at 8:00 a.m. ET.

Webcast: To join the live webcast with audio, go to http://ir.hill-rom.com/events.cfm or http://ir.hill-rom.com/eventdetail.cfm?eventid=131331. The webcast slide deck will be posted to the Hill-Rom website prior to the webcast.

Conference Call Audio Only Dial-in information: To join the live conference call, dial 877-304-8969 domestic callers / 631-291-4543 international callers. The following Confirmation Code is required for both: 97174013. Callers will need to provide their name, company affiliation and telephone number to the conference operator. A recording of the webcast/call audio will be available for telephone replay through July 31, 2013, domestically at 855-859-2056 and internationally at 404-537-3406. For the replay, callers will need to use confirmation code 97174013. If you are unable to listen to the live webcast or the telephone replay, the webcast will be archived at http://ir.hill-rom.com/events.cfm.

About Hill-Rom Holdings, Inc.

Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products and information technology solutions. Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom...enhancing outcomes for patients and their caregivers.

www.hill-rom.com

Disclosure Regarding Forward Looking Statements

Certain statements herein contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections. It is important to note that forward-looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward-looking statements. For a more in depth discussion of factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's previously filed most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation to update or revise any forward-looking statements.

Hill-Rom Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Income
(Dollars in millions except per share data)

			Quarter Ended June 30		Year To Date Ended June 30

			2013	2012	2013	2012
Net revenues
	Capital sales		$ 323.1	$ 300.6	$ 965.8	$ 868.1
	Rental revenues		101.1	105.9	312.5	334.6
		Total revenues	424.2	406.5	1,278.3	1,202.7
Cost of revenues
	Cost of goods sold		187.5	188.1	558.1	505.1
	Rental expenses		46.6	45.7	142.6	144.0
		Total cost of revenues	234.1	233.8	700.7	649.1
Gross profit
	Capital		135.6	112.5	407.7	363.0
	Rental		54.5	60.2	169.9	190.6
		Total gross profit	190.1	172.7	577.6	553.6
As a percentage of sales			44.8%	42.5%	45.2%	46.0%

Research and development expenses			16.7	16.1	52.2	48.2
Selling and administrative expenses			136.4	120.5	414.9	366.3
Impairment of other intangibles			-	-	-	8.0
Special charges			0.8	1.7	3.7	9.7


Operating profit			36.2	34.4	106.8	121.4

Other income/(expense), net			(2.3)	(1.0)	(7.6)	(2.8)

Income tax expense			10.5	10.0	29.5	37.0


Net income			$ 23.4	$ 23.4	$ 69.7	$ 81.6


Diluted earnings per share			$ 0.39	$ 0.37	$ 1.15	$ 1.31

Average common shares outstanding - diluted (thousands)			60,163	62,570	60,578	62,423

Dividends per common share			$ 0.1375	$ 0.1250	$ 0.3875	$ 0.3625

Non-GAAP Financial Disclosures and Reconciliations

While Hill-Rom reports financial results in accordance with U.S. GAAP, this press release includes non-GAAP measures. Hill-Rom uses the non-GAAP measures to evaluate and manage its operations and provides the information to assist investors in performing financial analysis that is consistent with financial models developed by research analysts. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

Hill-Rom Holdings, Inc. and Subsidiaries
Revenues - Constant Currency
(Dollars in millions)

	Quarter Ended June 30
	2013	Foreign Exchange	2013	2012	Constant Currency
	As Reported	Impact	Adjusted	As Reported	Change

Capital sales	$ 323.1	$ 1.1	$ 322.0	$ 300.6	7.1%
Rental revenues	101.1	-	101.1	105.9	-4.5%
Total	$ 424.2	$ 1.1	$ 423.1	$ 406.5	4.1%


North America	$ 238.9	$ (0.1)	$ 239.0	$ 240.8	-0.7%
Surgical and Respiratory Care	61.9	(0.2)	62.1	31.7	95.9%
International	123.4	1.4	122.0	134.0	-9.0%
Total	$ 424.2	$ 1.1	$ 423.1	$ 406.5	4.1%


	Year To Date Ended June 30
	2013	Foreign Exchange	2013	2012	Constant Currency
	As Reported	Impact	Adjusted	As Reported	Change

Capital sales	$ 965.8	$ (0.6)	$ 966.4	$ 868.1	11.3%
Rental revenues	312.5	(0.2)	312.7	334.6	-6.5%
Total	$ 1,278.3	$ (0.8)	$ 1,279.1	$ 1,202.7	6.4%


North America	$ 713.3	$ (0.1)	$ 713.4	$ 748.5	-4.7%
Surgical and Respiratory Care	182.1	(0.1)	182.2	97.6	86.7%
International	382.9	(0.6)	383.5	356.6	7.5%
Total	$ 1,278.3	$ (0.8)	$ 1,279.1	$ 1,202.7	6.4%

Hill-Rom Holdings, Inc. and Subsidiaries
Reconciliation: Earnings Per Share
(Dollars in millions except per share data)

	Quarter Ended June 30, 2013			Quarter Ended June 30, 2012
	Income Before Income Taxes	Income Tax Expense	Diluted EPS	Income Before Income Taxes	Income Tax Expense	Diluted EPS*

GAAP Earnings	$ 33.9	$ 10.5	$ 0.39	$ 33.4	$ 10.0	$ 0.37
Adjustments:
Acquisition and integration costs	1.2	0.4	0.01	1.9	0.7	0.02
Field corrective actions	4.5	1.2	0.06	16.0	5.9	0.16
FDA remediation expenses	2.2	0.8	0.02	-	-	-
Special charges	0.8	0.2	0.01	1.7	0.6	0.02
Vendor product recall	-	-	-	(1.7)	(0.7)	(0.02)

Adjusted Earnings	$ 42.6	$ 13.1	$ 0.49	$ 51.3	$ 16.5	$ 0.56





	Year To Date Ended June 30, 2013			Year To Date Ended June 30, 2012
	Income Before Income Taxes	Income Tax Expense	Diluted EPS	Income Before Income Taxes	Income Tax Expense	Diluted EPS*

GAAP Earnings	$ 99.2	$ 29.5	$ 1.15	$ 118.6	$ 37.0	$ 1.31
Adjustments:
Acquisition and integration costs	6.9	2.3	0.08	5.5	1.5	0.06
Field corrective actions	12.2	4.0	0.14	16.0	5.9	0.16
FDA remediation expenses	4.1	1.5	0.04	-	-	-
Litigation	0.5	0.5	-	-	-	-
Special charges	3.7	1.2	0.04	9.7	3.6	0.10
Impairment of other intangibles	-	-	-	8.0	2.1	0.09
Vendor product recall	-	-	-	(4.8)	(1.9)	(0.05)

Adjusted Earnings	$ 126.6	$ 39.0	$ 1.45	$ 153.0	$ 48.2	$ 1.68


* May not add due to rounding.



	Reconciliation: Adjusted EBITDA
	(Dollars in millions)

	Quarter Ended June 30		Year To Date Ended June 30
	2013	2012	2013	2012

Adjusted income before income taxes	$ 42.6	$ 51.3	$ 126.6	$ 153.0
Add back:
Other expense	2.3	1.0	7.6	2.8
Depreciation and amortization	28.6	27.0	88.8	80.7
Adjusted EBITDA	$ 73.5	$ 79.3	$ 223.0	$ 236.5

Hill-Rom Holdings, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(Dollars in millions)


			June 30, 2013	September 30, 2012
Assets
Current Assets
	Cash and cash equivalents		$ 91.3	$ 84.3
	Trade accounts receivable, net of allowances		361.2	392.6
	Inventories, net		122.8	126.9
	Other current assets		79.3	78.0
		Total current assets	654.6	681.8

Property, plant and equipment, net			237.6	250.1
Goodwill			338.7	335.2
Other assets			322.0	360.5

Total Assets			$ 1,552.9	$ 1,627.6

Liabilities
Current Liabilities
	Trade accounts payable		$ 65.6	$ 80.7
	Short-term borrowings		95.1	115.2
	Other current liabilities		181.7	182.2
		Total current liabilities	342.4	378.1

Long-term debt			229.5	237.5
Other long-term liabilities			176.1	199.4

Total Liabilities			748.0	815.0

Shareholders' Equity			804.9	812.6

Total Liabilities and Shareholders' Equity			$ 1,552.9	$ 1,627.6

Hill-Rom Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Dollars in millions)

			Year To Date Ended June 30

			2013	2012
Operating Activities
	Net income		$ 69.7	$ 81.6
	Adjustments to reconcile net income to net cash provided by
	operating activities:
		Depreciation	54.1	54.7
		Amortization	34.7	26.0
		Provision for deferred income taxes	(15.9)	(9.9)
		Loss on disposal of property, equipment leased to others,
		intangible assets and impairments	0.4	7.7
		Stock compensation	11.3	9.0
		Excess tax benefits from employee stock plans	(0.4)	(1.3)
		Change in working capital excluding cash, current investments,
		current debt and acquisitions and dispositions:
		Trade accounts receivable	31.4	46.0
		Inventories	3.9	(1.4)
		Other current assets	(2.4)	9.3
		Trade accounts payable	(15.1)	(11.8)
		Accrued expenses and other liabilities	(1.9)	(16.7)
		Other, net	(2.1)	(5.8)
Net cash provided by operating activities			167.7	187.4

Investing Activities
	Capital expenditures and purchase of intangibles		(49.7)	(55.9)
	Proceeds on sale of property and equipment leased to others		5.3	7.1
	Payment for acquisition of businesses, net of cash acquired		(0.2)	(77.0)
	Proceeds on investment sales and maturities		-	4.5
Net cash used in investing activities			(44.6)	(121.3)

Financing Activities
	Net change in short-term debt		(0.1)	(7.8)
	Net change in revolver		(20.0)	-
	Payment of long-term debt		(8.0)	(47.5)
	Purchase of noncontrolling interest		(1.3)	(1.3)
	Payment of cash dividends		(23.1)	(22.5)
	Proceeds on exercise of options		6.0	6.2
	Proceeds from stock issuance		2.1	2.2
	Excess tax benefits from employee stock plans		0.4	1.3
	Treasury stock acquired		(69.9)	(1.8)
Net cash used in financing activities			(113.9)	(71.2)

Effect of exchange rate changes on cash			(2.2)	0.5

Net Cash Flows			7.0	(4.6)

Cash and Cash Equivalents:
	At beginning of period		84.3	224.6
	At end of period		$ 91.3	$ 220.0

SOURCE Hill-Rom Holdings, Inc.